Live from the NIH registry
Studies recruiting near New Orleans right now
Top 25 of 554 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Tulane University Medical Center — New Orleans, Louisiana (11.8 mi)
· Sponsor: Syndax Pharmaceuticals
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation
Phase 1
Interventional 420 participants sought
Ochsner MD Anderson Cancer Center — Jefferson, Louisiana (15.2 mi)
· Sponsor: Kura Oncology, Inc.
Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair
Hiatal Hernia
N/A
Interventional 200 participants sought
Louisiana State University School of Medicine — New Orleans, Louisiana (11.8 mi)
· Sponsor: Weill Medical College of Cornell University
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Tulane University — New Orleans, Louisiana (11.8 mi)
· Sponsor: Jaeb Center for Health Research
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
East Jefferson Hospital — Metairie, Louisiana (14.6 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — New Orleans, Louisiana (11.8 mi)
· Sponsor: Sameek Roychowdhury
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Ochsner Clinic Foundation ( Site 0021) — New Orleans, Louisiana (11.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: Pfizer
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Louisiana State University Health Science Center — New Orleans, Louisiana (11.8 mi)
· Sponsor: NRG Oncology
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: NRG Oncology
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Clostridioides Difficile Infection
Phase 2
Interventional 230 participants sought
Research Site — New Orleans, Louisiana (11.8 mi)
· Sponsor: AstraZeneca
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
BRCR Global Louisiana — Gretna, Louisiana (13.0 mi)
· Sponsor: Alveus Therapeutics, Inc.
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
LSU Health Sciences — New Orleans, Louisiana (11.8 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Tandem Clinical Research — Metairie, Louisiana (14.6 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Phase 3
Interventional 105 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: Children's Oncology Group
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Phase 2
Interventional 200 participants sought
UMC New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: Novartis Pharmaceuticals
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
Refractory Metastatic Colorectal Cancer
Phase 2
Interventional 90 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (11.8 mi)
· Sponsor: Delcath Systems Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: NRG Oncology
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Tulane University School of Medicine — New Orleans, Louisiana (11.8 mi)
· Sponsor: Sparrow Pharmaceuticals
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
Lung Cancer Screening, Tobacco Use Disorder
N/A
Interventional 250 participants sought
LSUHSC School of Public Health — New Orleans, Louisiana (11.8 mi)
· Sponsor: Louisiana State University Health Sciences Center in New Orleans
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Louisiana State University Health Science Center — New Orleans, Louisiana (11.8 mi)
· Sponsor: NRG Oncology
Randomized Clinical Trial of Re-Evaluating Suicidal Thoughts in Veterans
Suicidal Ideation, Suicide, Attempted
N/A
Interventional 180 participants sought
Southeast Louisiana Veterans Health Care System, New Orleans, LA — New Orleans, Louisiana (11.8 mi)
· Sponsor: VA Office of Research and Development
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
Solid Tumor
Phase 1
Interventional 105 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (11.8 mi)
· Sponsor: ImmunoGenesis
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Low Grade Serous Ovarian Cancer
Phase 3
Interventional 270 participants sought
Louisiana State University — New Orleans, Louisiana (11.8 mi)
· Sponsor: Verastem, Inc.